The Potential Use of Salivary miRNAs as Promising Biomarkers for Detection of Cancer: A Meta-Analysis.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 27832115)

Published in PLoS One on November 10, 2016

Authors

Yuanjie Ding1, Qing Ma2, Fen Liu1, Lei Zhao3, Wenqiang Wei2

Author Affiliations

1: Department of Epidemiology and Health Statistics, School of Public Health, Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China.
2: Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
3: Department of Molecular Physiology and Biophysics, Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, Iowa City, IA, United States of America.

Articles cited by this

MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59

Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52

A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med (2011) 15.02

Cancer statistics in China, 2015. CA Cancer J Clin (2016) 12.92

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol (2005) 10.56

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ (2001) 9.63

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol (2005) 7.06

The microRNA spectrum in 12 body fluids. Clin Chem (2010) 6.82

Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol (2006) 6.60

Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res (2009) 3.86

Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg (2000) 2.48

A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess (2005) 2.24

Saliva: an emerging biofluid for early detection of diseases. Am J Dent (2009) 1.91

Esophageal cancer--the five year survivors. J Surg Oncol (2010) 1.30

Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS One (2013) 1.10

High resolution of microRNA signatures in human whole saliva. Arch Oral Biol (2011) 1.09

Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res (Phila) (2014) 0.97

Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. J Dent Res (2014) 0.96

Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers-Part II. Statistical Methods of Meta-Analysis. Korean J Radiol (2015) 0.93

Salivary MicroRNA in Pancreatic Cancer Patients. PLoS One (2015) 0.86

[Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer]. Nan Fang Yi Ke Da Xue Xue Bao (2014) 0.84

[miRNA-144 in the saliva is a genetic marker for early diagnosis of esophageal cancer]. Nan Fang Yi Ke Da Xue Xue Bao (2013) 0.83

Saliva supernatant miR-21: a novel potential biomarker for esophageal cancer detection. Asian Pac J Cancer Prev (2012) 0.83

Diagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva. EXS (2015) 0.81